Feedback / Questions
eblasakimab (ASLAN004) - ASLAN Pharma, Zenyaku Holdings
https://www.globenewswire.com/news-release/2024/04/22/2866887/0/en/ASLAN-Pharmaceuticals-Announces-Positive-Interim-Results-From-Phase-2-Study-of-Eblasakimab-in-Dupilumab-Experienced-Atopic-Dermatitis-Patients.html
Apr 22, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next